Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?

Gut Liver. 2021 Mar 15;15(2):149-150. doi: 10.5009/gnl210098.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adalimumab / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Colitis, Ulcerative* / drug therapy
  • Humans
  • Infliximab / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab
  • Adalimumab